Manchester United Ltd. Cl A (MANU) Financials Nov 18, 2014,
Manchester United Ltd. Cl A (MANU) Financials Nov 18, 2014, 7:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Manchester United Ltd. Cl A
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 452.12M 526.89M 507.24M 569.33M 703.63M
Cost of Goods Sold (COGS) incl. D&A 284.78M 316.59M 328.47M 360.55M 452.81M
COGS excluding D&A 207.88M 243.09M 256.04M 282.98M 348.92M
Depreciation & Amortization Expense 76.91M 73.5M 72.43M 77.57M 103.89M
Depreciation 13.63M 11.11M 11.84M 12.18M 14.08M
Amortization of Intangibles 63.28M 62.39M 60.59M 65.39M 89.81M
Gross Income 167.33M 210.31M 178.77M 208.77M 250.82M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 82.22M 110.13M 105.36M 117.08M 136.73M
Research & Development 0 0 0 0 -
Other SG&A 82.22M 110.13M 105.36M 117.08M 136.73M
Other Operating Expense 0 0 0 0 0
Unusual Expense 23.06M 8.1M 17.43M 9.2M 9.94M
EBIT after Unusual Expense (23.06M) (8.1M) (17.43M) (9.2M) (9.94M)
Non Operating Income/Expense (9.79M) 33.74M 5.87M 10.14M (295,638)
Non-Operating Interest Income 2.71M 2.72M 1.23M 2M 415,843
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 124.85M 109.45M 70.46M 108.41M 38.48M
Gross Interest Expense 124.85M 109.45M 70.46M 108.41M 38.48M
Interest Capitalized 0 0 0 0 0
Pretax Income (69.89M) 19.08M (7.39M) (13.78M) 65.79M
Income Tax 5.07M (1.57M) (44.3M) (243.31M) 27.08M
Income Tax - Current Domestic 0 6.9M - (2M) 243,658
Income Tax - Current Foreign 93,134 205,072 - 769,682 2.39M
Income Tax - Deferred Domestic 4.98M (8.67M) - (14.66M) 8.75M
Income Tax - Deferred Foreign 0 0 - (227.42M) 15.69M
Income Tax Credits 0 0 - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (74.96M) 20.65M 36.92M 229.52M 38.72M
Minority Interest Expense 430,941 542,089 517,814 264,921 0
Net Income (75.39M) 20.11M 36.4M 229.26M 38.72M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (75.39M) 20.11M 36.4M 229.26M 38.72M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (75.39M) 20.11M 36.4M 229.26M 38.72M
EPS (Basic) (0.46) 0.13 0.22 1.41 0.24
Basic Shares Outstanding 163.69M 163.69M 163.69M 162.9M 163.81M
EPS (Diluted) (0.46) 0.13 0.22 1.41 0.24
Diluted Shares Outstanding 163.69M 163.69M 163.69M 162.9M 163.89M
EBITDA 162.02M 173.67M 145.83M 169.26M 217.98M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...
Continue Reading
Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...
Continue Reading
Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...
Continue Reading
Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...
Continue Reading
A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...
Continue Reading
Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...
Continue Reading
Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...
Continue Reading
Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Human-Machine Interface Market The global human-machine interface (HMI) market is currently valued at about USD 4.07 billion and is expected to grow significantly, possibly reaching USD 10.64 billion within the next decade. This remarkable growth reflects a compound annual growth rate (CAGR) of 10.1%. The importance of Human-Machine Interfaces stems from...
Continue Reading
Leadership Transition at Mattel, Inc. Mattel, Inc. (NASDAQ: MAT), the recognized leader in toy production, has announced a significant transition within its executive team as its Chief Financial Officer, Anthony DiSilvestro, has plans to retire. The planned retirement is set for May, with the company actively searching for DiSilvestro's successor. The transition strategy...
Continue Reading
Groundbreaking Steps in Cancer Treatment with REC-3565 Recursion, a trailblazer in the TechBio realm, has announced an exciting new development: the first patient has been dosed in a Phase 1 clinical study of REC-3565, a selective MALT1 inhibitor aimed at treating relapsed or refractory B-cell lymphomas. This endeavor signifies a pivotal moment in the realm of...
Continue Reading
Legal Challenges Faced by Dow Inc. As one of the leading companies in materials science solutions, Dow Inc. (NYSE: DOW) is currently facing significant legal challenges that are affecting its investors. The ongoing situation involves a class action lawsuit aimed at protecting shareholders who bought Dow securities between late January and late July. The legal proceedings...
Continue Reading
Palvella Therapeutics Appoints New Chief Innovation Officer Palvella Therapeutics, Inc. has recently announced the appointment of Dr. David W. Osborne as their Chief Innovation Officer. With over 25 years of exceptional experience in the pharmaceutical industry, Dr. Osborne brings a wealth of knowledge in developing innovative therapies for serious, rare genetic skin...
Continue Reading